Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Infection control in patients with myelodysplastic syndromes who are candidates for active treatment: Expert panel consensus-based recommendations.

Girmenia C, Candoni A, Delia M, Latagliata R, Molteni A, Oliva EN, Palumbo GA, Poloni A, Salutari P, Santini V, Voso MT, Musto P.

Blood Rev. 2018 Oct 28. pii: S0268-960X(18)30069-9. doi: 10.1016/j.blre.2018.10.002. [Epub ahead of print] Review.

PMID:
30448050
2.

Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study.

Messa E, Gioia D, Masiera E, Castiglione A, Ceccarelli M, Salvi F, Danise P, Sanna A, Allione B, Balleari E, Poloni A, Cametti G, Ferrero D, Tassara R, Finelli C, Bonferroni M, Musto P, Saglio G, Levis A, Santini V.

Haematologica. 2019 Jan;104(1):e4-e8. doi: 10.3324/haematol.2017.183590. Epub 2018 Aug 3. No abstract available.

3.

Increasing soft tissue thickness does not affect trabecular bone score reproducibility: a phantom study.

Messina C, Poloni A, Chianca V, Albano D, Piodi LP, Ulivieri FM, Sconfienza LM.

Endocrine. 2018 Aug;61(2):336-342. doi: 10.1007/s12020-018-1647-8. Epub 2018 Jun 15.

PMID:
29948934
4.

Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes.

Mattiucci D, Maurizi G, Leoni P, Poloni A.

Cell Transplant. 2018 May;27(5):754-764. doi: 10.1177/0963689717745890. Epub 2018 Apr 23.

5.

Immunomodulatory Effects of Tyrosine Kinase Inhibitor In Vitro and In Vivo Study.

Marinelli Busilacchi E, Costantini A, Viola N, Costantini B, Olivieri J, Butini L, Mancini G, Scortechini I, Chiarucci M, Poiani M, Poloni A, Leoni P, Olivieri A.

Biol Blood Marrow Transplant. 2018 Feb;24(2):267-275. doi: 10.1016/j.bbmt.2017.10.039. Epub 2017 Nov 8.

PMID:
29128554
6.

ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems.

Buckstein R, Balleari E, Wells R, Santini V, Sanna A, Salvetti C, Crisà E, Allione B, Danise P, Finelli C, Clavio M, Poloni A, Salvi F, Cilloni D, Oliva EN, Musto P, Houston B, Zhu N, Geddes M, Leitch H, Leber B, Sabloff M, Nevill TJ, Yee KW, Storring JM, Francis J, Maurillo L, Latagliata R, Spiriti MAA, Andriani A, Piccioni AL, Fianchi L, Fenu S, Gumenyuk S, Buccisano F.

Am J Hematol. 2017 Oct;92(10):1037-1046. doi: 10.1002/ajh.24842. Epub 2017 Jul 29.

7.

A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia.

Santini V, Allione B, Zini G, Gioia D, Lunghi M, Poloni A, Cilloni D, Sanna A, Masiera E, Ceccarelli M, Abdel-Wahab O, Terenzi A, Angelucci E, Finelli C, Onida F, Pelizzari A, Ferrero D, Saglio G, Figueroa M, Levis A.

Leukemia. 2018 Feb;32(2):413-418. doi: 10.1038/leu.2017.186. Epub 2017 Jun 13.

8.

Bone marrow adipocytes support hematopoietic stem cell survival.

Mattiucci D, Maurizi G, Izzi V, Cenci L, Ciarlantini M, Mancini S, Mensà E, Pascarella R, Vivarelli M, Olivieri A, Leoni P, Poloni A.

J Cell Physiol. 2018 Feb;233(2):1500-1511. doi: 10.1002/jcp.26037. Epub 2017 Aug 3.

PMID:
28574591
9.

Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study.

Musto P, Maurillo L, Simeon V, Poloni A, Finelli C, Balleari E, Ricco A, Rivellini F, Cortelezzi A, Tarantini G, Villani O, Mansueto G, Milella MR, Scapicchio D, Marziano G, Breccia M, Niscola P, Sanna A, Clissa C, Voso MT, Fenu S, Venditti A, Santini V, Angelucci E, Levis A.

Br J Haematol. 2017 Jun;177(5):741-750. doi: 10.1111/bjh.14621. Epub 2017 Apr 17.

PMID:
28419408
10.

Feasibility of allogeneic stem-cell transplantation after azacitidine bridge in higher-risk myelodysplastic syndromes and low blast count acute myeloid leukemia: results of the BMT-AZA prospective study.

Voso MT, Leone G, Piciocchi A, Fianchi L, Santarone S, Candoni A, Criscuolo M, Masciulli A, Cerqui E, Molteni A, Finelli C, Parma M, Poloni A, Carella AM, Spina F, Cortelezzi A, Salvi F, Alessandrino EP, Rambaldi A, Sica S.

Ann Oncol. 2017 Jul 1;28(7):1547-1553. doi: 10.1093/annonc/mdx154.

PMID:
28368509
11.

Adipocytes properties and crosstalk with immune system in obesity-related inflammation.

Maurizi G, Della Guardia L, Maurizi A, Poloni A.

J Cell Physiol. 2018 Jan;233(1):88-97. doi: 10.1002/jcp.25855. Epub 2017 May 3. Review.

PMID:
28181253
12.

Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial.

Oliva EN, Alati C, Santini V, Poloni A, Molteni A, Niscola P, Salvi F, Sanpaolo G, Balleari E, Germing U, Fenaux P, Stamatoullas A, Palumbo GA, Salutari P, Impera S, Avanzini P, Cortelezzi A, Liberati AM, Carluccio P, Buccisano F, Voso MT, Mancini S, Kulasekararaj A, Morabito F, Bocchia M, Cufari P, Spiriti MA, Santacaterina I, D'Errigo MG, Bova I, Zini G, Latagliata R.

Lancet Haematol. 2017 Mar;4(3):e127-e136. doi: 10.1016/S2352-3026(17)30012-1. Epub 2017 Feb 3.

PMID:
28162984
13.

Human White Adipocytes Convert Into "Rainbow" Adipocytes In Vitro.

Maurizi G, Poloni A, Mattiucci D, Santi S, Maurizi A, Izzi V, Giuliani A, Mancini S, Zingaretti MC, Perugini J, Severi I, Falconi M, Vivarelli M, Rippo MR, Corvera S, Giordano A, Leoni P, Cinti S.

J Cell Physiol. 2017 Oct;232(10):2887-2899. doi: 10.1002/jcp.25743. Epub 2017 Apr 12.

PMID:
27987321
14.

DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype.

Maurizi G, Mattiucci D, Mariani M, Ciarlantini M, Traini S, Mancini S, Olivieri A, Leoni P, Poloni A.

Br J Haematol. 2017 Jun;177(5):818-822. doi: 10.1111/bjh.14115. Epub 2016 Apr 22. No abstract available.

PMID:
27102230
15.

Relevant incidental findings at abdominal multi-detector contrast-enhanced computed tomography: A collateral screening?

Sconfienza LM, Mauri G, Muzzupappa C, Poloni A, Bandirali M, Esseridou A, Tritella S, Secchi F, Di Leo G, Sardanelli F.

World J Radiol. 2015 Oct 28;7(10):350-6. doi: 10.4329/wjr.v7.i10.350.

16.

Host specificity in Sporisorium reilianum is determined by distinct mechanisms in maize and sorghum.

Poloni A, Schirawski J.

Mol Plant Pathol. 2016 Jun;17(5):741-54. doi: 10.1111/mpp.12326. Epub 2015 Nov 11.

PMID:
26419898
17.

Early lenalidomide treatment for low and intermediate-1 International Prognostic Scoring System risk myelodysplastic syndromes with del(5q) before transfusion dependence.

Oliva EN, Lauseker M, Aloe Spiriti MA, Poloni A, Cortelezzi A, Palumbo GA, Balleari E, Sanpaolo G, Volpe A, Ricco A, Ronco F, Alati C, D'Errigo MG, Santacaterina I, Kündgen A, Germing U, Latagliata R.

Cancer Med. 2015 Dec;4(12):1789-97. doi: 10.1002/cam4.523. Epub 2015 Sep 17.

18.

Interaction between human mature adipocytes and lymphocytes induces T-cell proliferation.

Poloni A, Maurizi G, Ciarlantini M, Medici M, Mattiucci D, Mancini S, Maurizi A, Falconi M, Olivieri A, Leoni P.

Cytotherapy. 2015 Sep;17(9):1292-301. doi: 10.1016/j.jcyt.2015.06.007.

PMID:
26276010
19.

Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia.

Meldi K, Qin T, Buchi F, Droin N, Sotzen J, Micol JB, Selimoglu-Buet D, Masala E, Allione B, Gioia D, Poloni A, Lunghi M, Solary E, Abdel-Wahab O, Santini V, Figueroa ME.

J Clin Invest. 2015 May;125(5):1857-72. doi: 10.1172/JCI78752. Epub 2015 Mar 30.

20.

Short-term precision assessment of trabecular bone score and bone mineral density using dual-energy X-ray absorptiometry with different scan modes: an in vivo study.

Bandirali M, Poloni A, Sconfienza LM, Messina C, Papini GD, Petrini M, Ulivieri FM, Di Leo G, Sardanelli F.

Eur Radiol. 2015 Jul;25(7):2194-8. doi: 10.1007/s00330-015-3606-6. Epub 2015 Feb 8.

PMID:
25663312
21.

Biosafety evidence for human dedifferentiated adipocytes.

Poloni A, Maurizi G, Mattiucci D, Busilacchi E, Mancini S, Discepoli G, Amici A, Falconi M, Cinti S, Leoni P.

J Cell Physiol. 2015 Jul;230(7):1525-33. doi: 10.1002/jcp.24898.

PMID:
25641257
22.

Plasticity of human dedifferentiated adipocytes toward endothelial cells.

Poloni A, Maurizi G, Anastasi S, Mondini E, Mattiucci D, Discepoli G, Tiberi F, Mancini S, Partelli S, Maurizi A, Cinti S, Olivieri A, Leoni P.

Exp Hematol. 2015 Feb;43(2):137-46. doi: 10.1016/j.exphem.2014.10.003. Epub 2014 Oct 24.

PMID:
25448487
23.

Managing osteoporosis in ulcerative colitis: something new?

Piodi LP, Poloni A, Ulivieri FM.

World J Gastroenterol. 2014 Oct 21;20(39):14087-98. doi: 10.3748/wjg.v20.i39.14087. Review.

24.

Glial-like differentiation potential of human mature adipocytes.

Poloni A, Maurizi G, Foia F, Mondini E, Mattiucci D, Ambrogini P, Lattanzi D, Mancini S, Falconi M, Cinti S, Olivieri A, Leoni P.

J Mol Neurosci. 2015 Jan;55(1):91-98. doi: 10.1007/s12031-014-0345-0. Epub 2014 Jul 10.

PMID:
25007949
25.

Red card for pathogens: phytoalexins in sorghum and maize.

Poloni A, Schirawski J.

Molecules. 2014 Jun 30;19(7):9114-33. doi: 10.3390/molecules19079114. Review.

26.

Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes.

Poloni A, Maurizi G, Mattiucci D, Amatori S, Fogliardi B, Costantini B, Mariani M, Mancini S, Olivieri A, Fanelli M, Leoni P.

Leukemia. 2014 Nov;28(11):2241-4. doi: 10.1038/leu.2014.197. Epub 2014 Jun 19. No abstract available.

PMID:
24943834
27.

Mobilization-driven postconsolidation therapy in elderly patients with acute myeloid leukemia: feasibility and efficacy of autologous stem cell transplantation versus low-dose gemtuzumab ozogamicin.

Capelli D, Chiarucci M, Poloni A, Saraceni F, Mancini G, Trappolini S, Troiani E, Montanari M, Scortechini I, Offidani M, Rupoli S, Scortechini AR, Gini G, Discepoli G, Leoni P, Olivieri A.

Biol Blood Marrow Transplant. 2014 Sep;20(9):1399-406. doi: 10.1016/j.bbmt.2014.05.019. Epub 2014 May 28.

28.

Valproic acid for the treatment of low-risk myelodysplastic syndromes: A case report and a review of the literature.

Poloni A, Costantini B, Mariani M, Leoni P.

Leuk Res Rep. 2013 Jun 11;2(2):44-6. doi: 10.1016/j.lrr.2013.03.003. eCollection 2013.

29.

Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD.

Olivieri A, Cimminiello M, Corradini P, Mordini N, Fedele R, Selleri C, Onida F, Patriarca F, Pavone E, Svegliati S, Gabrielli A, Bresciani P, Nuccorini R, Pascale S, Coluzzi S, Pane F, Poloni A, Olivieri J, Leoni P, Bacigalupo A.

Blood. 2013 Dec 12;122(25):4111-8. doi: 10.1182/blood-2013-05-494278. Epub 2013 Oct 23.

30.

Telomere length, c-myc and mad-1 expression could represent prognosis markers of myelodysplastic syndrome.

Poloni A, Serrani F, Berardinelli E, Maurizi G, Mariani M, Costantini B, Trappolini S, Mancini S, Olivieri A, Leoni P.

Leuk Res. 2013 Nov;37(11):1538-44. doi: 10.1016/j.leukres.2013.07.022. Epub 2013 Oct 3.

PMID:
24095110
31.

Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?

Santini V, Schemenau J, Levis A, Balleari E, Sapena R, Adès L, Guerci A, Beyne-Rauzy O, Gourin MP, Cheze S, Stamatoullas A, Sanna A, Gioia D, Cametti G, Ferrero D, Raffoux E, Rose C, Poloni A, Prebet T, Legros L, Natarajan-Amé S, Fenaux P, Germing U, Dreyfus F, Park S.

Blood. 2013 Sep 26;122(13):2286-8. doi: 10.1182/blood-2013-07-512442. No abstract available.

32.

Conditioning regimen with BCNU, etoposide, cytarabine and melphalan plus amifostine for outpatient autologous stem cell transplant: feasibility and outcome in 97 patients with lymphoma.

Scortechini I, Montanari M, Mancini G, Inglese E, Calandrelli M, Chiarucci M, Offidani M, Capelli D, Gini G, Poloni A, Mancini S, Raggetti G, Leoni P, Olivieri A.

Leuk Lymphoma. 2014 Jul;55(7):1657-60. doi: 10.3109/10428194.2013.842989. Epub 2013 Nov 1. No abstract available.

PMID:
24024474
33.

Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes.

Poloni A, Goteri G, Zizzi A, Serrani F, Trappolini S, Costantini B, Mariani M, Olivieri A, Catarini M, Centurioni R, Alesiani F, Giantomassi F, Stramazzotti D, Biagetti S, Alfonsi S, Berardinelli E, Leoni P.

Eur J Haematol. 2013 Sep;91(3):219-27. doi: 10.1111/ejh.12145. Epub 2013 Jun 28.

PMID:
23679560
34.

Low FasL levels promote proliferation of human bone marrow-derived mesenchymal stem cells, higher levels inhibit their differentiation into adipocytes.

Rippo MR, Babini L, Prattichizzo F, Graciotti L, Fulgenzi G, Tomassoni Ardori F, Olivieri F, Borghetti G, Cinti S, Poloni A, Fazioli F, Procopio AD.

Cell Death Dis. 2013 Apr 18;4:e594. doi: 10.1038/cddis.2013.115.

35.

Molecular and functional characterization of human bone marrow adipocytes.

Poloni A, Maurizi G, Serrani F, Mancini S, Zingaretti MC, Frontini A, Cinti S, Olivieri A, Leoni P.

Exp Hematol. 2013 Jun;41(6):558-566.e2. doi: 10.1016/j.exphem.2013.02.005. Epub 2013 Feb 19.

PMID:
23435314
36.

Lenalidomide in International Prognostic Scoring System Low and Intermediate-1 risk myelodysplastic syndromes with del(5q): an Italian phase II trial of health-related quality of life, safety and efficacy.

Oliva EN, Latagliata R, Laganà C, Breccia M, Galimberti S, Morabito F, Poloni A, Balleari E, Cortelezzi A, Palumbo G, Sanpaolo G, Volpe A, Specchia G, Finelli C, D'Errigo MG, Rodà F, Alati C, Alimena G, Nobile F, Aloe Spiriti MA.

Leuk Lymphoma. 2013 Nov;54(11):2458-65. doi: 10.3109/10428194.2013.778406. Epub 2013 Mar 27.

PMID:
23432724
37.

Rapid loss of response after withdrawal of treatment with azacitidine: a case series in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia.

Voso MT, Breccia M, Lunghi M, Poloni A, Niscola P, Finelli C, Bari A, Musto P, Zambello R, Fianchi L, Alimena G, Leone G.

Eur J Haematol. 2013 Apr;90(4):345-8. doi: 10.1111/ejh.12079. Epub 2013 Feb 28.

PMID:
23336938
38.

Biological activity of lenalidomide in myelodysplastic syndromes with del5q: results of gene expression profiling from a multicenter phase II study.

Oliva EN, Cuzzola M, Aloe Spiriti MA, Poloni A, Laganà C, Rigolino C, Morabito F, Galimberti S, Ghio R, Cortelezzi A, Palumbo GA, Sanpaolo G, Finelli C, Ricco A, Volpe A, Rodà F, Breccia M, Alimena G, Nobile F, Latagliata R.

Ann Hematol. 2013 Jan;92(1):25-32. doi: 10.1007/s00277-012-1569-0. Epub 2012 Sep 16.

PMID:
22983750
39.

Quality of life and physicians' perception in myelodysplastic syndromes.

Oliva EN, Finelli C, Santini V, Poloni A, Liso V, Cilloni D, Impera S, Terenzi A, Levis A, Cortelezzi A, Ghio R, Musto P, Semenzato G, Clissa C, Lunghi T, Trappolini S, Gaidano V, Salvi F, Reda G, Villani O, Binotto G, Cufari P, Cavalieri E, Spiriti MA.

Am J Blood Res. 2012;2(2):136-47. Epub 2012 May 25.

40.

Tailored therapy in an unselected population of 91 elderly patients with DLBCL prospectively evaluated using a simplified CGA.

Olivieri A, Gini G, Bocci C, Montanari M, Trappolini S, Olivieri J, Brunori M, Catarini M, Guiducci B, Isidori A, Alesiani F, Giuliodori L, Marcellini M, Visani G, Poloni A, Leoni P.

Oncologist. 2012;17(5):663-72. doi: 10.1634/theoncologist.2011-0355. Epub 2012 Apr 24.

41.

Human dedifferentiated adipocytes show similar properties to bone marrow-derived mesenchymal stem cells.

Poloni A, Maurizi G, Leoni P, Serrani F, Mancini S, Frontini A, Zingaretti MC, Siquini W, Sarzani R, Cinti S.

Stem Cells. 2012 May;30(5):965-74. doi: 10.1002/stem.1067.

42.

Human AB serum for generation of mesenchymal stem cells from human chorionic villi: comparison with other source and other media including platelet lysate.

Poloni A, Maurizi G, Serrani F, Mancini S, Discepoli G, Tranquilli AL, Bencivenga R, Leoni P.

Cell Prolif. 2012 Feb;45(1):66-75. doi: 10.1111/j.1365-2184.2011.00799.x. Epub 2011 Dec 14.

PMID:
22168227
43.

Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning.

Poloni A, Sartini D, Emanuelli M, Trappolini S, Mancini S, Pozzi V, Costantini B, Serrani F, Berardinelli E, Renzi E, Olivieri A, Leoni P.

Cytokine. 2011 Mar;53(3):376-83. doi: 10.1016/j.cyto.2010.12.008. Epub 2011 Jan 5.

PMID:
21211989
44.

Human mesenchymal stem cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in vitro expansion.

Poloni A, Maurizi G, Babini L, Serrani F, Berardinelli E, Mancini S, Costantini B, Discepoli G, Leoni P.

Cell Transplant. 2011;20(5):643-54. doi: 10.3727/096368910X536518. Epub 2010 Nov 5.

PMID:
21054927
45.

Changes in RPS14 expression levels during lenalidomide treatment in Low- and Intermediate-1-risk myelodysplastic syndromes with chromosome 5q deletion.

Oliva EN, Cuzzola M, Nobile F, Ronco F, D'Errigo MG, Laganà C, Morabito F, Galimberti S, Cortelezzi A, Aloe Spiriti MA, Specchia G, Poloni A, Breccia M, Ghio R, Finelli C, Iacopino P, Alimena G, Latagliata R.

Eur J Haematol. 2010 Sep;85(3):231-5. doi: 10.1111/j.1600-0609.2010.01473.x. Epub 2010 May 17.

PMID:
20491881
46.

Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study.

Poloni A, Capelli D, Trappolini S, Costantini B, Montanari M, Gini G, Scortechini I, Mancini G, Discepoli G, Leoni P, Olivieri A.

Br J Haematol. 2010 Jul;150(1):119-21. doi: 10.1111/j.1365-2141.2010.08168.x. Epub 2010 Apr 5. No abstract available.

PMID:
20377587
47.

Morphology, physiology, and virulence of Bipolaris sorokiniana isolates.

Poloni A, Pessi IS, Frazzon AP, Van der Sand ST.

Curr Microbiol. 2009 Sep;59(3):267-73. doi: 10.1007/s00284-009-9429-4. Epub 2009 May 30.

PMID:
19484298
48.

Selection of CD271(+) cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow.

Poloni A, Maurizi G, Rosini V, Mondini E, Mancini S, Discepoli G, Biasio S, Battaglini G, Felicetti S, Berardinelli E, Serrani F, Leoni P.

Cytotherapy. 2009;11(2):153-62. doi: 10.1080/14653240802582125.

PMID:
19301169
49.

Characterization and expansion of mesenchymal progenitor cells from first-trimester chorionic villi of human placenta.

Poloni A, Rosini V, Mondini E, Maurizi G, Mancini S, Discepoli G, Biasio S, Battaglini G, Berardinelli E, Serrani F, Leoni P.

Cytotherapy. 2008;10(7):690-7. doi: 10.1080/14653240802419310.

PMID:
18985476
50.

Vegetative incompatibility among monoconidial isolates of Bipolaris sorokiniana.

Poloni A, Pessi IS, Frazzon AP, Van Der Sand ST.

Curr Microbiol. 2009 Feb;58(2):153-8. doi: 10.1007/s00284-008-9292-8. Epub 2008 Oct 25.

PMID:
18953604

Supplemental Content

Loading ...
Support Center